Xeris Biopharma Holdings, Inc. (XERS) Cash Flow Quarterly - Discounting Cash Flows
XERS
Xeris Biopharma Holdings, Inc.
XERS (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2025 (Q3)
09-30
2025 (Q2)
06-30
2025 (Q1)
03-31
2024 (Q4)
12-31
2024 (Q3)
09-30
2024 (Q2)
06-30
2024 (Q1)
03-31
2023 (Q4)
12-31
2023 (Q3)
09-30
2023 (Q2)
06-30
2023 (Q1)
03-31
2022 (Q4)
12-31
2022 (Q3)
09-30
2022 (Q2)
06-30
2022 (Q1)
03-31
2021 (Q4)
12-31
2021 (Q3)
09-30
2021 (Q2)
06-30
2021 (Q1)
03-31
2020 (Q4)
12-31
2020 (Q3)
09-30
2020 (Q2)
06-30
2020 (Q1)
03-31
2019 (Q4)
12-31
2019 (Q3)
09-30
2019 (Q2)
06-30
2019 (Q1)
03-31
2018 (Q4)
12-31
2018 (Q3)
09-30
2018 (Q2)
06-30
2018 (Q1)
03-31
2017 (Q4)
12-31
2017 (Q3)
09-30
2017 (Q2)
06-30
2017 (Q1)
03-31
Report Filing: 2025-11-06 2025-11-06 2025-08-07 2025-05-08 2025-03-06 2024-11-08 2024-08-08
1234
Net Income/Starting Line -15.64 0.621 -1.93 -9.22 -5.11 -15.74 -15.01
1234
Cash From Operating Activities 10.56 18.43 0.182 -10.03 1.98 -8.3 -10.35
1234
Depreciation and Amortization 12.24 3.05 2.92 3.14 3.13 2.68 3.15
1234
Deferred Income Tax 0 0 0 0 0 -3.32 0.749
1234
Stock Based Compensation 20.69 7.64 5.01 4.44 3.6 6.77 4.23
1234
Other Non-Cash Items 3.73 0.983 1.07 0.844 0.834 -7.71 -0.092
1234
Changes in Working Capital -10.46 6.14 -6.88 -9.24 -0.474 9.02 -3.39
1234
Accounts Receivable -12.61 -0.703 -6.72 -5.92 0.723 1.3 -5.03
1234
Inventory -18.41 -4.08 -7.57 -3.62 -3.14 -1.05 -2.27
1234
Accounts Payable -3.57 2 -4.43 4.06 -5.2 1.65 -1.59
1234
Deferred Revenue 24.14 8.93 11.84 -3.77 7.14 7.11 5.5
1234
Other Working Capital 0 0 0 0 0 0 0
1234
Cash From Investing Activities 9.65 -0.071 -0.279 -0.013 10.02 9.91 4.6
1234
Investments in Property Plant and Equipment -0.583 -0.363 0.013 -0.013 -0.22 -0.087 -0.397
1234
Payments for Acquisitions 0 0 0 0 0 0 0
1234
Purchases of Securities 0 0 0 0 0 -5 -5
1234
Sales and Maturities of Investments 10.24 0 0 0 10.24 15 10
1234
Other Investing Activities 0 0.292 -0.292 0 0 0 0
1234
Cash From Financing Activities 12.05 13.85 0.942 -3.14 0.398 -0.083 0.659
1234
Debt Repayment 0 0 0 0 0 0 0
1234
Common Stock Issued 14.33 14.33 0 0 0 0 0
1234
Common Stock Repurchased -0.644 -0.478 8 -8 -0.166 -0.083 -0.051
1234
Dividends Paid 0 0 0 0 0 0 0
1234
Other Financing Activities 5.42 0 0 4.86 0.564 0 0.71
1234
Effect of Forex Changes on Cash 0 0 0 0 0 0 0
1234
Net Change in Cash 19.88 32.21 0.845 -13.18 12.39 1.53 -5.09
1234
Cash at Beginning of Period 75.74 63.41 58.44 75.74 63.35 61.83 62.69
1234
Cash at End of Period 95.62 95.62 59.28 62.56 75.74 63.35 57.6
1234
Free Cash Flow 19.82 18.07 10.04 -10.04 1.75 -8.39 -10.74
1234
Operating Cash Flow 10.56 18.43 0.182 -10.03 1.98 -8.3 -10.35
1234
Capital Expenditure -0.583 -0.363 0.013 -0.013 -0.22 -0.087 -0.397
1234
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program